Sage Therapeutics(SAGE) - 2023 Q4 - Earnings Call Presentation

Fourth Quarter and Full Year 2023 Financial Results February 14, 2024 Safe Harbor Statement the diseases or disorders our products treat or the subset of such patients webelieve will use our products, the need for new treatment options, and the actual market for suchproducts may be smaller than our • The slides presentedtodayand the accompanying oral presentations contain forward-lookingstatements, current estimates. which may be identifiedby the use ofwords such as “may,” “might,” “will,” “should,”“can,” “ ...